Combinatorial blockade of calcineurin and CD28 signaling facilitates primary and secondary therapeutic gene transfer by adenovirus vectors in dystrophic (mdx) mouse muscles

Journal of Virology

Volumn 72, Issue 6, 1998, Pages 4601-4609

  Guibinga, Ghiabe Henri ^a   Lochmuller, Hanns ^b,c   Massie, Bernard ^d   Nalbantoglu, Josephine ^b   Karpati, George ^b   Petrof, Basil J ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF MUNICH   (Germany)

^d NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CD2 ANTIGEN; CD28 ANTIGEN; CYCLOSPORIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DYSTROPHIN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; TACROLIMUS; VIRUS PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG MECHANISM; DRUG TOLERABILITY; DUCHENNE MUSCULAR DYSTROPHY; GENE EXPRESSION REGULATION; GENE THERAPY; HUMORAL IMMUNITY; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031902429     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.6.4601-4609.1998     Document Type: Article

References (48)

1. Acsadi, G., A. Jani, B. Massie, M. Simoneau, P. Holland, and G. Karpati. 1994. A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum. Mol. Genet. 3:579-584.
2. Acsadi, G., H. Lochmuller, A. Jani, J. Huard, B. Massie, S. Prescott, M. Simoneau, B. J. Petrof, and G. Karpati. 1996. Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. Hum. Gene Ther. 7:129-140.
3. Ahmad, A., and J. Menezes. 1996. Antibody-dependent cellular cytotoxicity in HIV infections. FASEB J. 10:258-266.
4. Chavin, K., H. T. Lau, and J. S. Bromberg. 1992. Prolongation of allograft and xenograft survival in mice by anti-CD2 monoclonal antibodies. Transplantation 54:286-291.
5. Clemens, P. R., S. Kochanek, Y. Sunada, S. Chan, H.-H. Chen, K. P. Campbell, and C. T. Caskey. 1996. In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes. Gene Ther. 3: 965-972.
6. Cruz-Orive, L. M., and E. R. Weibel. 1990. Recent stereological methods for cell biology: a brief survey. Am. J. Physiol. 258:L148-L156.
7. Davis, H. L., C. L. Brazolot, and S. C. Watkins. 1997. Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA. Gene Ther. 4:181-188.
8. Deconinck, N., T. Ragot, G. Marechal, M. Perricaudet, and J. M. Gillis. 1996. Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. Proc. Natl. Acad. Sci. USA 93:3570-3574.
9. Epstein, F. H. 1996. Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N. Engl. J. Med. 335:1369-1375.
10. Fisher, K. J., K. Jooss, J. Alston, Y. Yang, S. E. Haecker, K. High, R. Pathak, S. E. Raper, and J. M. Wilson. 1997. Recombinant adeno-associated virus for muscle directed gene therapy. Nat. Med. 3:306-312.
11. Galvin, F., G. J. Freeman, Z. Razi-Wolf, B. Benacerraf, L. Nadler, and H. Reiser. 1993. Effects of cyclosporin A, FK506, and mycalamide A on the activation of murine CD4+ T cells by the murine B7 antigen. Eur. J. Immunol. 23:283-286.
12. Gao, G.-P., Y. Yang, and J. M. Wilson. 1996. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J. Virol. 70:8934-8943.
13. Guckel, B., C. Berek, M. Lutz, P. Altevogt, V. Schirrmacher, and B. A. Kyewski. 1991. Anti-CD2 antibodies induce T cell unresponsiveness in vivo. J. Exp. Med. 174:957-967.
14. Guerette, B., J. T. Vilquin, M. Gingras, C. Gravel, K. J. Wood, and J. P. Tremblay. 1996. Prevention of immune reactions triggered by first-generation adenoviral vectors by monoclonal antibodies and CTLA4Ig. Hum. Gene Ther. 7:1455-1463.
15. Guinan, E. C., J. G. Gribben, V. A. Boussiotis, G. J. Freeman, and L. M. Nadler. 1994. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 84:3261-3282.
16. Haecker, S. E., H. H. Stedman, R. J. Balice-Gordon, D. B. J. Smith, J. P. Greelish, M. A. Mitchell, A. Wells, H. L. Sweeney, and J. M. Wilson. 1996. In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes. Hum. Gene Ther. 7:1907-1914.
17. Hoffman, E. P., R. H. J. Brown, and L. M. Kunkel. 1987. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:919-928.
18. Hoffman, E. P., J. E. Morgan, S. C. Watkins, and T. A. Partridge. 1990. Somatic reversion/suppression of the mouse mdx phenotype in vivo. J. Neurol. Sci. 99:9-25.
19. Isobe, M., H. Yagita, K. Okumura, and A. Ihara. 1992. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 255:1125-1127.
20. Jooss, K., Y. Yang, and J. M. Wilson. 1996. Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung. Hum. Gene Ther. 7:1555-1566.
21. Jane, C. H., J. A. Ledbetter, M. M. Gillespie, T. Lindsten, and C. B. Thompson. 1987. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell. Biol. 7:4472-4481.
22. Kay, M. A., A. Holterman, L. Meuse, A. Gown, H. D. Ochs, P. S. Linsley, and C. B. Wilson. 1995. Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nat. Gene. 11:191-197.
23. Kay, M. A., L. Meuse, A. M. Gown, P. Linsley, D. Hollenbaugh, A. Aruffo, H. D. Ochs, and C. B. Wilson. 1997. Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver. Proc. Natl. Acad. Sci. USA 94:4686-4691.
24. Lenschow, D. J., Y. Zeng, J. R. Thistlethwaite, A. Montag, W. Brady, M. G. Gibson, P. S. Linsley, and J. A. Bluestone. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257:789-792.
25. Lin, H., S. F. Bolling, P. S. Linsley, R.-Q. Wei, D. Gordon, C. B. Thompson, and L. A. Turka. 1993. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J. Exp. Med. 178:1801-1806.
26. Linsley, P. S., P. M. Wallace, J. Johnson, M. G. Gibson, J. L. Greene, J. A. Ledbetter, C. Singh, and M. A. Tepper. 1992. Immunosuppression in vivo by soluble form of the CTLA-4 T cell activation molecule. Science 257:792-795.
27. Liu, J., J. D. Farmer, W. S. Lane, J. Friedman, I. Weissman, and S. L. Schreiber. 1991. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66:807-815.
28. Lochmuller, H., B. J. Petrof, G. Pari, N. Larochelle, V. Dodelet, Q. Wang, C. Allen, S. Prescott, B. Massie, J. Nalbantoglu, and G. Karpati. 1996. Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice. Gene Ther. 3:706-716.
29. Lochmüller, H., A. J. J. Huard, S. Prescott, M. Simoneau, B. Massie, G. Karpati, and G. Acsadi. 1994. Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants during multiple passages in 293 cells. Hum. Gene Ther. 5: 1485-1491.
30. Menke, A., and H. Jockusch. 1991. Decreased osmotic stability of dystrophin-less muscle cells from the mdx mouse. Nature 349:69-71.
31. Michou, A. I., L. Santoro, M. Christ, V. Juillard, A. Pavirani, and M. Mehtali. 1997. Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression. Gene Ther. 4:473-482.
32. Moingeon, P. E., J. L. Lucich, C. C. Stebbins, M. A. Recny, B. P. Wallner, S. Koyasu, and E. L. Reinherz. 1991. Complementary roles for CD2 and LFA-1 adhesion pathways during T cell activation. Eur. J. Immunol. 21:605-610.
33. Petrof, B. J., G. Acsadi, A. Jani, B. Massie, J. Bourdon, N. Matusiewicz, L. Yang, H. Lochmuller, and G. Karpati. 1995. Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm. Am. J. Respir. Cell Mol. Biol. 13:508-517.
34. + T cell deficiency. Hum. Gene Ther. 7:1813-1826.
35. Petrof, B. J., J. B. Shrager, H. H. Stedman, A. M. Kelly, and H. L. Sweeney. 1993. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. USA 90:3710-3714.
36. Ragot, T., N. Vincent, P. Chafey, E. Vigne, H. Gilgenkrantz, D. Couton, J. Cartaud, P. Briand, J. C. Kaplan, M. Perricaudet, and A. Kahn. 1993. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361:647-650.
37. Tripathy, S. K., H. B. Black, E. Goldwasser, and J. M. Leiden. 1996. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 2: 545-550.
38. Vilquin, J.-T., E. Wagner, I. Kinoshita, R. Roy, and J. P. Tremblay. 1995. Successful histocompatible transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin. J. Cell Biol. 131:975-988.
39. Waterhouse, P., J. M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K. P. Lee, C. B. Thompson, H. Griesser, and T. W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in ctla-4. Science 270: 985-988.
40. Xiao, X., J. Li, and R. J. Samulski. 1996. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70:8098-8108.
41. Yang, L., H. Lochmuller, J. Luo, B. Massie, J. Nalbantoglu, G. Karpati, and B. J. Petrof. Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice. Gene Ther., in press.
42. Yang, V., S. E. Haecker, Q. Su, and J. M. Wilson. 1996. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Hum. Mol. Genet. 5:1703-1712.
43. Yang, Y., J. Ku, Q. Su, H. C. J. Ertl, and J. M. Wilson. 1996. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther. 3:137-144.
44. Yang, Y., Q. Li, H. C. J. Ertl, and J. M. Wilson. 1995. Cellular and humoral immune response to viral antigens create barriers to lung-directed gene therapy with recombinant adenovirus. J. Virol. 69:2004-2015.
45. Yang, Y., F. A. Nunes, K. Berencsi, E. Gonczol, J. F. Engelhardt, and J. M. Wilson. 1994. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat. Gene. 7:362-369.
46. Yang, Y., Q. Su, I. S. Grewal, R. Schilz, R. A. Flavell, and J. M. Wilson. 1996. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues. J. Virol. 70:6370-6377.
47. Yang, Y., Q. Su, and J. M. Wilson. 1996. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs J. Virol. 70:7209-7212.
48. Yang, Y., Z. Xiang, H. C. J. Ertl, and J. M. Wilson. 1995. Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 92:7257-7261.